Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,258 | 226 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $680.92 | 60 | $0 (2024) |
| PFIZER INC. | $477.53 | 40 | $0 (2024) |
| Tris Pharma Inc | $429.04 | 26 | $0 (2024) |
| Lilly USA, LLC | $381.73 | 26 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $229.52 | 13 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $228.80 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $108.36 | 6 | $0 (2024) |
| Novo Nordisk Inc | $102.98 | 6 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $73.86 | 4 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $62.42 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,462 | 103 | ABBVIE INC. ($315.42) |
| 2023 | $1,402 | 100 | ABBVIE INC. ($303.57) |
| 2022 | $394.21 | 23 | Tris Pharma Inc ($75.13) |
All Payment Transactions
226 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Gastroenterology | ||||||
| 12/10/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: ADHD | ||||||
| 12/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: RESPIRATORY | ||||||
| 12/06/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: NEUROSCIENCE | ||||||
| 11/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.42 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $10.91 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: VACCINES | ||||||
| 11/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/15/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $5.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Bone Health | ||||||
| 11/11/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: ADHD | ||||||
| 11/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $2.76 | General |
| Category: PAIN | ||||||
| 11/04/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Hepatitis B Vaccine | ||||||
| 11/01/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Oncology | ||||||
| 10/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Gastroenterology | ||||||
| 10/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Gastroenterology | ||||||
| 10/04/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $7.61 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/02/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: PAIN | ||||||
| 10/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,072 | 1,446 | $227,609 | $94,748 |
| 2022 | 9 | 272 | 331 | $47,083 | $21,124 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 235 | 472 | $89,680 | $38,527 | 43.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 36 | 36 | $25,560 | $10,121 | 39.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 71 | 71 | $19,028 | $8,326 | 43.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 99 | 108 | $14,580 | $6,149 | 42.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 78 | 78 | $14,352 | $5,611 | 39.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 37 | 37 | $11,692 | $5,571 | 47.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 55 | 55 | $13,475 | $5,379 | 39.9% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2023 | 38 | 40 | $11,600 | $3,528 | 30.4% |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | Office | 2023 | 55 | 59 | $6,018 | $2,967 | 49.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 36 | 38 | $5,206 | $2,284 | 43.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 78 | 79 | $3,871 | $2,216 | 57.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 150 | 261 | $6,264 | $2,169 | 34.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 36 | 36 | $1,800 | $1,010 | 56.1% |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | Office | 2023 | 12 | 13 | $1,638 | $447.07 | 27.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 21 | 22 | $1,364 | $209.44 | 15.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 21 | $1,281 | $191.91 | 15.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 19 | 20 | $200.00 | $44.00 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 78 | 112 | $21,280 | $10,126 | 47.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 43 | 47 | $6,345 | $3,113 | 49.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $4,655 | $2,181 | 46.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 13 | 13 | $3,484 | $1,547 | 44.4% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2022 | 14 | 14 | $4,060 | $1,314 | 32.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 17 | 18 | $2,754 | $1,234 | 44.8% |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | Office | 2022 | 17 | 18 | $1,836 | $905.04 | 49.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 19 | 20 | $989.00 | $500.27 | 50.6% |
About John Martin
John Martin is a Family Medicine healthcare provider based in Hattiesburg, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2019. The National Provider Identifier (NPI) number assigned to this provider is 1114489507.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, John Martin has received a total of $3,258 in payments from pharmaceutical and medical device companies, with $1,462 received in 2024. These payments were reported across 226 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($3,258).
As a Medicare-enrolled provider, Martin has provided services to 1,344 Medicare beneficiaries, totaling 1,777 services with total Medicare billing of $115,872. Data is available for 2 years (2022–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Hattiesburg, MS
- Active Since 04/03/2019
- Last Updated 07/19/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1114489507
Products in Payments
- Dyanavel XR (Drug) $429.04
- NURTEC ODT (Drug) $273.33
- MOUNJARO (Drug) $259.73
- QULIPTA (Drug) $247.16
- VRAYLAR (Drug) $232.77
- XARELTO (Drug) $228.80
- JARDIANCE (Drug) $203.46
- PREVNAR 20 (Biological) $162.08
- UBRELVY (Drug) $149.66
- TRULICITY (Drug) $82.41
- Kerendia (Drug) $73.86
- LEQVIO (Drug) $71.53
- XIFAXAN (Drug) $62.42
- EVENITY (Biological) $59.95
- LINZESS (Drug) $47.00
- QUVIVIQ (Drug) $44.38
- Wegovy (Drug) $38.71
- TRUMENBA (Biological) $38.17
- ENTRESTO (Drug) $36.83
- TRINTELLIX (Drug) $35.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Hattiesburg
Omolara Otaigbe, Md, MD
Family Medicine — Payments: $28,883
Dr. Deborah Copeland, M.d, M.D
Family Medicine — Payments: $16,017
Mr. J Dumas, Md, MD
Family Medicine — Payments: $15,138
Dr. Melanie Hall, M.d, M.D
Family Medicine — Payments: $12,717
Dr. Stephen Lambert, Md, MD
Family Medicine — Payments: $9,907
Dr. Rambod Rouhbakhsh, Md, MD
Family Medicine — Payments: $9,437